Clinical Chemistry Analyzer Market on the Rise: What’s Driving Demand?
Scott Wallask, BA
To capture new demand, clinical labs should note advancing technology and rising disease mortality
Cardiovascular Disease
New, Simple Test Detects Rare Fatal Genetic Heart Condition
McMaster University
The new test will allow clinicians to identify individuals at risk of a life-threatening genetic heart arrhythmia
Roche Granted FDA Breakthrough Device Designation for Blood Test Measuring Lipoprotein (a)—a Key Marker for Hereditary Cardiovascular Risk
Roche
Lp(a), is emerging as an important, yet under-recognized, potential risk factor for cardiovascular disease, a major public health issue
Genetic Factors Linked to Atrial Fibrillation Could Drive CVDs
Elsevier
The paper analyzes current understanding of genetics in atrial fibrillation and recommends screening for genetic heart disease in early-onset cases
Current Tools Underestimate CVD Risk in People with HIV
National Institutes of Health
Trial reveals the need for more accurate screening in Black people and cisgender women
New Biomarker-Based Model Predicts Imminent Risk of Heart Attack
Swathi Kodaikal, MSc
Some 48 proteins, 43 metabolites, age, sex, and systolic blood pressure were associated with the risk of first heart attack
Blood Biomarkers in Patients with Arthritis Predict CVD Risk
Mass General Brigham
The six blood biomarkers improved predictions about arterial inflammation—an indicator of cardiovascular risk
More Biomarkers to Predict Heart Disease in People with T2D
Johns Hopkins Medicine
These biomarkers have the potential to change clinical practice to better predict cardiovascular risk
Insulin Resistance and Cardiometabolic Health
Michael Schubert, PhD
Michael McPhaul, MD, discusses advances in insulin resistance testing
New Hepatitis E, Diabetes Tests Included in WHO’s Essential Diagnostics Lists
World Health Organization
EDLs will help countries develop national and international IVD policies to deliver better patient care